Nivalis Therapeutics, Inc.
COMPANY
S-4
FORM
2017-05-19
FILING DATE
2017-03-31
PERIOD END
792
FACTS
SIC 2834
CIK 0001626199
Taxonomy US GAAP 2016
SIC 2834
CIK 0001626199
Taxonomy US GAAP 2016
Standard Concepts
291
Extended Concepts
55
16%
Extended Concepts
Errors
0
What are errors?
What are errors?
Indicate problems with an XBRL formatted filing that are sufficient grounds for SEC rejection of the XBRL portion of the filing.
Data Quality Errors
0
What are data quality errors?
What are data quality errors?
Indicate areas that may not meet the standards set by the Data Quality Committee (DQC), and may reveal areas where the XBRL can be improved.